Accepted
at 10:04 a.m. Oct, 26, 2023
by
Ahmed7
Author:
galacticescapist
Co-authors:
Ahmed7
Type of change:
Updated content
Rationale for change
The triad for aspirin exacerbated respiratory disease is as follows:
1. Asthma
2. Nasal polyps
3. COX-inhibitor sensitivity
So in the card chronic/recurrent rhinosinusitis should be replaced by COX-inhibitor sensitivity.
Source: First aid 2023 page 695
Before
After
Extra
Extra
Extra
Extra
Text
{{c1::Aspirin-exacerbated respiratory disease (AERD)}} is characterized by a triad of:
Asthma
Chronic / recurrent rhinosinusitis with nasal polyps
Hypersensitivity to aspirin or other COX-1 inhibitors
Asthma
Chronic / recurrent rhinosinusitis with nasal polyps
Hypersensitivity to aspirin or other COX-1 inhibitors
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Asthma & Bronchiectasis



Watch Asthma & Bronchiectasis
Sketchy 2



Watch Chronic Asthma SOA







Watch Chronic Asthma SOA




Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Asthma
Watch associated Bootcamp video - Pharmacology : Aspirin & Celecoxib
Watch associated Bootcamp video - Pharmacology : Aspirin & Celecoxib
OME
Additional Resources


Shunting of the arachidonic acid pathway toward the leukotriene (LOX) pathway; treat with leukotriene antagonists (montelukast, zafirlukast); diagnose with aspirin challenge


One by one
Empty field
